UPDATE : Thursday, September 12, 2019
상단여백
Celltrion will use Oracle Health platform to streamline processes by Marian Chu 2017-09-27 10:47
Can Celltrion, Samsung make stable earnings with biosimilar? by Nam Doo-hyun 2017-09-26 17:31
Medifron aims high through R&D by Lee Han-soo 2017-09-25 16:19
Korea lags far behind in biomedical R&D: report by Nam Doo-hyun 2017-09-21 16:14
Biosimilar prescriptions fall by the wayside in Korea by Marian Chu 2017-09-21 14:56
라인
Samsung Bioepis gets additional approval for its biosimilar by Lee Hye-seon 2017-09-21 12:03
MSD dissolves promotion team for Samsung Bioepis’ biosimilars by Lee Han-soo 2017-09-21 11:58
Sillajen emerges as biggest beneficiary of preferential listing by Nam Doo-hyun 2017-09-20 17:22
Samsung Bioepis gets nods for phase 3 trials to treat macular degeneration by Lee Han-soo 2017-09-19 17:39
Korean biopharmaceutical industry ranked 2nd among emerging countries by Marian Chu 2017-09-19 10:37
라인
EU approvals for Samsung Bioepis push up share prices by Nam Doo-hyun 2017-09-18 14:45
Genexin, Handok presents persistent growth hormone clinical trial results by Lee Han-soo 2017-09-18 14:39
Celltrion in controversy over sexual harassment case by Lee Han-soo 2017-09-15 18:11
‘Knowledge’ is core ability for bio industrialists, survey says by Nam Doo-hyun 2017-09-15 16:28
Access Bio, PFSCM sign supply agreement for malaria kit by Lee Han-soo 2017-09-15 14:52
라인
‘BIOplus Incheon 2017’ shares product-developing know-how by Lee Han-soo 2017-09-14 11:14
Medipost to commercialize new stem cell-culture tech by Constance Williams 2017-09-14 10:38
Hanall Biopharma made $81-million technology export to China by Lee Hye-seon 2017-09-13 13:23
New VC investments in bio, medical fields fall sharpest in H1 by Nam Doo-hyun 2017-09-13 13:23
Celltrion presents Herzuma’s clinical results in Europe by Lee Han-soo 2017-09-11 12:19
여백
여백
여백
Back to Top